<?xml version="1.0" encoding="UTF-8"?>
<p>To determine whether sfRNA is packaged in virions or infectious particles containing DENV envelope (E) protein and are thus infectious, we used a pan-DENV monoclonal antibody, 4G2, to enrich for E-containing infectious particles in the culture supernatant. An overview of the experiment is shown in 
 <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1919287117/-/DCSupplemental" xlink:show="new" xmlns:xlink="http://www.w3.org/1999/xlink">
  <italic>SI Appendix</italic>, Fig. S5
  <italic>A</italic>
 </ext-link>. In brief, optimized levels of magnetic bead-conjugated monoclonal antibody 4G2 that binds DENV E protein (
 <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1919287117/-/DCSupplemental" xlink:show="new" xmlns:xlink="http://www.w3.org/1999/xlink">
  <italic>SI Appendix</italic>, Fig. S5
  <italic>B</italic>
 </ext-link>) was incubated with the culture supernatant of PR1- and PR2B-infected cells. The precipitate was subjected to RNase treatment (
 <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1919287117/-/DCSupplemental" xlink:show="new" xmlns:xlink="http://www.w3.org/1999/xlink">
  <italic>SI Appendix</italic>, Fig. S5
  <italic>C</italic>
 </ext-link>) to remove unpackaged viral RNA before viral envelope was digested for viral RNA extraction. RT-qPCR showed that gRNA copies were detectable in all viruses except PR1NS5 (
 <xref ref-type="fig" rid="fig04">Fig. 4
  <italic>C</italic>
 </xref>). Interestingly, sfRNA copies were detected in PR1NS5, PR1NS53UTR, and PR2B but not in PR1 and PR13UTR (
 <xref ref-type="fig" rid="fig04">Fig. 4
  <italic>D</italic>
 </xref>). Correspondingly, sfRNA:gRNA ratios in PR1NS5, PR1NS53UTR, and PR2B were increased (
 <xref ref-type="fig" rid="fig04">Fig. 4
  <italic>E</italic>
 </xref>). These findings suggest that sfRNA could be packaged in infectious particles. However, the 4G2 pull-down precipitate also contained exosomes (CD63) (
 <xref ref-type="fig" rid="fig04">Fig. 4
  <italic>F</italic>
 </xref>). To delineate whether sfRNA is packaged exclusively in virions, we used CD63 antibodies to deplete exosomes from culture supernatants before subjecting them to 4G2 pull-down (
 <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1919287117/-/DCSupplemental" xlink:show="new" xmlns:xlink="http://www.w3.org/1999/xlink">
  <italic>SI Appendix</italic>, Fig. S5
  <italic>A</italic>
 </ext-link>). While exosomes could be removed from PR1 culture supernatant, they could not be fully depleted in PR2B culture supernatant (
 <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1919287117/-/DCSupplemental" xlink:show="new" xmlns:xlink="http://www.w3.org/1999/xlink">
  <italic>SI Appendix</italic>, Fig. S5
  <italic>D</italic>
 </ext-link>), and sfRNA:gRNA ratios remained higher in PR2B compared with PR1 (
 <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1919287117/-/DCSupplemental" xlink:show="new" xmlns:xlink="http://www.w3.org/1999/xlink">
  <italic>SI Appendix</italic>, Fig. S5 
  <italic>Eâ€“G</italic>
 </ext-link>). Taken together, these findings suggest that sfRNA may be packaged in DENV E protein-containing particles, including both exosomes and virions.
</p>
